Clinical Trials Logo

Filter by:
NCT ID: NCT03802422 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Vitamin B12 for Carpal Tunnel Syndrome

Start date: April 20, 2019
Phase: N/A
Study type: Interventional

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. Rather than other progressive disease, CTS is characterized by remission and recurrence. The hydrodissection could decrease the entrapment of nerve to restore blood supply. In addition, the Vitamin B12 was considered to be beneficial for peripheral neuropathy and pain relief. The investigators design a randomized, double-blind, controlled trail to assess the effect after ultrasound-guided hydrodissection with Vitamin B12 in patients with CTS.

NCT ID: NCT03735160 Withdrawn - Clinical trials for Intubation Complication

Pressure Over Nasotracheal Intubation Related Nasal Alar Injury

Start date: May 1, 2020
Phase:
Study type: Observational

Nasotracheal intubation can cause injury and hemorrhage of nasal mucosa and nasal alar. The investigators measure the actual pressure at the angle between nasotracheal tube and nasal alar, analyze the relationship of clinical signs and symptoms to build up optimal clinical routines.

NCT ID: NCT03695822 Withdrawn - Clinical trials for Overactive Bladder Syndrome

Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome

Start date: December 24, 2018
Phase: Phase 4
Study type: Interventional

We will get the impact of mirabegron on psychological distress, urethra and bladder blood flow and c reactive protein.

NCT ID: NCT03671473 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Comparison of Focused and Radial Extracorporeal Shock Wave for Carpal Tunnel Syndrome

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Extracorporeal shock wave is a novel treatment for peripheral nerve entrapment. This study was designed to compare the efficacy of focused and radial extracorporeal shock wave for carpal tunnel syndrome.

NCT ID: NCT03629015 Withdrawn - Clinical trials for Acute-On-Chronic Liver Failure

Safety Study of Stemchymal® in Acute Liver Failure

ALF
Start date: October 1, 2018
Phase: Phase 1
Study type: Interventional

To investigate the safety of Stemchymal® via intravenous (IV) infusion in acute liver failure (ALF) and acute on chronic liver failure (ACLF) patients.

NCT ID: NCT03551639 Withdrawn - Clinical trials for Microsporidial Keratoconjunctivitis

Application of Real-time PCR Platform for Detection of Vittaforma Corneae Among Patients With Microsporidia Keratitis

MK
Start date: January 1, 2016
Phase:
Study type: Observational

Diagnosis of patients with microsporiosis relies on pathological findings as well as laboratory detection of the causative organism. The conventional laboratory diagnosis of microsporiosis relies on microscopic visualization of the characteristic V. Corneae organisms. We develop a fully automated molecular platform for detection of Vittaforma corneae among patients with microsporidia keratitis.

NCT ID: NCT03502694 Withdrawn - Metapneumovirus Clinical Trials

Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus

STEP
Start date: November 5, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine in hospitalized adult participants infected with human metapneumovirus (hMPV - a virus closely related to respiratory syncytial virus (RSV) and has been identified as an important cause of acute respiratory infections, affecting all age groups) the dose-response relationship of multiple regimens of lumicitabine on antiviral activity based on nasal hMPV shedding using quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) assay.

NCT ID: NCT03417037 Withdrawn - Lung Cancer Clinical Trials

An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer

Start date: May 24, 2018
Phase: Phase 3
Study type: Interventional

This is a study of experimental medication BMS-986205 given with Nivolumab with or without chemotherapy compared to chemotherapy in participants with previously untreated stage IV or recurrent non-small cell lung cancer.

NCT ID: NCT03230370 Withdrawn - Clinical trials for Poststroke/CVA Hemiparesis

Does the Enhanced Rehabilitation Programs Facilitate the Motor Recovery After Stroke?

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

Study purpose This study will explore whether an additional rehabilitation program that focus on either upper or lower extremity training facilitate the recovery in upper or lower extremity. The recovery in both neurological status and motor functions will be explored.

NCT ID: NCT03214887 Withdrawn - Clinical trials for Critical Limb Ischemia

Autologous BMMNC Combined With HA Therapy for PAOD

Start date: January 17, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of hyaluronan combined with autologous bone marrow mononuclear cells for the treatment of critical PAOD patients.